Fong Peter
SEC CIK 2062181 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | Dir | 76.2K | — | — | 2 | 2025-09-24 | 2026-06-18 |
Most active insiders at RCKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilson Martin | GC | — | $334.6K |
| 2 | Shah Gaurav | CEO, Dir | — | $285.6K |
| 3 | Militello John | See Remarks | — | $138.3K |
| 4 | Stevens Christopher James | COO | — | $128.3K |
| 5 | Chaudhuri Sarbani | See Remarks | — | $84.2K |
| 6 | Bjork Elisabeth | Dir | $34.4K | — |
| 7 | Schwartz Jonathan David | See Remarks | — | $7,584 |
| 8 | Fong Peter | Dir | — | — |
| 9 | Rizvi Syed Ali-aamir | Chief Medical Off | — | — |
| 10 | Malik Fady Ibraham | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-06 20:00 | 2026-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Fong Peter | Dir | A - Grant | $0.00 | +22.9K | 76.2K | +43% | $0 |
| M | 2025-10-03 | 2025-09-24 | RCKT | ROCKET PHARMACEUTICALS, INC. | Fong Peter | Dir | A - Grant | $0.00 | +53.3K | 53.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations